REFERENCES

• 1. Winner SJ, Evans JG (1990) Age specific incidence of GBS in Oxfordshire. Q J Med 77: 1297-1304
• 2. Halls J, Bredkjaer C, Friis ML (1998) Guillain- Barre syndrome; diagnostic criteria, epidemiology, clinical course and prognosis. Acta Neurol Scand 78: 118-122
• 3. Guillain G, Barre JA, Strohl A. Sur un syndrome de radiculonebrite avec hyperalbuminose du liquide cephalo-rachidien sans reaction cellulaire. Remarques sur les caracteres cliniques et graphiques des reflexes tendineux. Bull. soc. Med. Hop. Paris 1916; 40:1462
• 4. Asbury AK, Cornblath DR. Assessment of Current Diagnostic Criteria for Guillain-Barre Syndrome. Ann Neurol 1990; 7(suppl): S21-S24.
• 5. Ho T, Griffin J, Guillain-Barre Syndrome. Curr Opin Neurol 1999; 12:389-394.
• 6. Paradiso G, Tripoli J, galicchio S, Fejerman N. Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain-Barre syndrome: a reappraisal. Ann Neurol 1999;46:701-707
• 7. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia ataxia and areflexia). New Eng J Med 1956; 255:57-65.
• 8. Roper AH, Wijdicks EFM, Traux BT. Guillain-Barre Syndrome. Philidelphia: FA Davis;1991
• 9. Winer JB, Hughes RAC, Anderson MJ, Jones DM, Kangros H, Watkins RPF. A prospective study of acute idiopathic neuropathy.11 Antecedent events. J Neurol Neurosurg Psychiatry. 1988;51: 613-618
• 10. R. D'Alessandro Risk factors for GBS: A population based case control study. J Nuerol (1999) 246: 1004-1009
• 11. Hughes RAC, Choudhary PP, Osborn M, et al. Immunisation and risk of collapse in Guillain-Barre syndrome or chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1996;19:1230-1.
• 12. Melnick SC, Flewett TH. Role of infection in the Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1964;27:395-407.
• 13. Kennedy RH, Danielson MA, Mulder DW, Kurland P. Guillain-Barre syndrome- a 42 year epidemiological and clinical study. Mato Clin Proc 1978;53:93-99
• 14. Rees JH, Thompson RD, Smeeton NC, Hughes RA. Epidemiological study of Guillain-Barre syndrome in south east England. J Neurol Neurosurg Psychiatry 1998; 64:74-77
• 15. Griffin JW, Li CY, Ho TW, et al. Guillain-Barre syndrome in northern China; the spectrum of neuropathological changes in clinically defined cases. Brain 1995;118:597-605
• 16. Asbury K.Asbury,MD.New concepts of Guillain-Barre Syndrome.J Of Child Neurol March 2000: Vol15.No3:183-191.
• 17. Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiological classification of Guillain-Barre syndrome: clinical association and outcome: Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Ann Neurol 1998;44:780-788
• 18. French Co-operative Group on Plasma Exchange in Guillain-Barre Syndrome. Appropriate number of plasma exchanges in Guillain-Barre Syndrome. Ann Neurol 1997;41:298-306.
• 19. French Co-operative Group on plasma Exchange in Guillain-Barre Syndrome. Role of replacement fluids. Ann Neurol 1987;22:753-761.
• 20.. French Cooperative Group in Plasma Exchange in Guillain-Barre Syndrome. Plasma Exchange in Guillain-Barre syndrome: one year follow-up. Ann Neurol 1992;32:94-97
• 21. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group.Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome.Lancet 1997;349:225-230.
• 22 Wong BLY, Glauser TA: Single high-dose intravenous immunoglobulin for treatment of pediatric Guillain-Barre syndrome, letter. J Child Neurol 1998;13:146
• 23 Zafeiriou DI, Kontopoulos EE, Katzos GS et al: Single High-Dose Immunoglobulin Therapy For Childhood Guillain-Barre Syndrome, letter. j Child Neurol 1999;14:481
• 24 Hughes RA. Van der Meche FG.Corticosteroids for treating Guillain-Barre syndrome. Cochrane Database of Systemic Reviews(2):CD001446,2000.
• 25 Lichtenfeld P. Autonomic Dysfunction in the Guillain-Barre syndrome. Am J Med 1970;50:772-780
• 26 Winer JB, Hughes RAC. Identification of patients at risk for arrhythmia in the Guillain-Barre syndrome. Q J Med 1988;257:735-739
• 27 Zochodne DW. Autonomic involvement in Guillain-Barre syndrome:a review. Muscle Nerve 1994;17:1145-1155
• 28 Raphael JC, Masson C, Morice V, Brunel, Gajdos P, Barios A, Goulan M. Le syndrome de Landry-Guillain Barre. Rev Neurol (Paris)1986;142:613-624
• 29 Pfeiffer G, Schiller B, Netzer J. Indicators of dysautonomia in severe Guillain-Barre syndrome. J Neurol 1999;246:1015-1022
• 30 Greenland P, Griggs RC. Arrhythmic complications in the Guillain-Barre syndrome. Arch Intern Med 1980;140:1096-1104
• 31 Minahan RE, Bhardwaj a, traill TA, Hanley DF. Stimulus evoked sinus arrest in severe Guillain-Barre syndrome: a case report. Neurology 1996;47:1239-1242
• 32 Hughes RAC, Bihari D. Acute neuromuscular respiratory paralysis. In : Hughes RAC; ed. Neurological emergencies. 2nd edn. London: BMJ Publishibg, 1997: 295-319
• 33 Chevrolet JC, Deleamont P. Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain-Barre Syndrome. Am Rev Respir Dis 1991;144:814-818.
• 34 Roper AH, Kehne SM. Guillain-Barre Syndrome: management of respiratory failure. Neurology 1985;35:1662-1665.
• 35 Zifko U, Chen R, Hahn AF, Koopman W, Bolton CF. Respiratory electrophysiologicaal studies in Guillain-Barre syndrome. J Neurol Neurosurg Psycgiatry 1996;60:191-194
• 36 Rantala H. Uhari M. Cherry JD. Shields WD. Risk factors of respiratory failure in children with Guillain-Barre syndrome.Ped. Neurol;1995:13(4):289-92
• 37 Robilliard C, Tempest-Roe J. After GBS: Information for patients recovering from Guillain-Barre syndrome,2000. pg 21.
• 38 Lancet 1990 338:37-39.
• 39 Roper AH, Shahani BT: Pain in Guillain-Barre syndrome. Arch Neurol 1984:41; 511-514
• 40 Moulin De, Hagen N, Feasby TE, et al: Pain in Guillain-Barre syndrome. Neurology 1997;48:328-331
• 41 Dwight E. Moulin,MD. Pain in central and peripheral demyelinating disorders.Neurological Clinics 1998;16;889-896.
• 42 Valdrighi JB, Hanowell LH, Loeb RG, et al: Effect of intraoperative ketorolac on postanaesthesia care unit comfort. J Pain Symptom Manage 1994;9:171-174
• 43 Gurwitz JH, Avorn J, Ross-Degnan D, et al: Nonsteroidal anti-inflammatory drug-associaed azotimia in the very old. JAMA 1990; 264:471-475
• 44 Allison MC, Howatson GI, Torrance CJ, et al: Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Eng J Med 1992;327: 749-754
• 45 Mukesh Tripati. Caramazepine for pain management in GBS patients in the intensive Care Unit. Crit Care Med 2000 Vol.28, No.3
• 46 Segal AZ, Rordorf G: Gabapentin as a novel treatment for postherpetic neuralgia. Neurology 1996;46:1175-1176.
• 47 Derdak.S:Neuromuscular disorders. In:Critical Care. Civetta JM, Taylor RW, Kirby RR( Eds). Philidelphia, Lippincott-Raven,1997,pp 2005-2015.
• 48 Lennon SM, Koblar S, Hughes RAC et al. Reasons for persistent disbilty in Guillain-Barre syndrome. Clin Rehab 1993;7:1-8.
• 49 Strickland C, Tempest-Roe J. Exercise. After GBS:2000 pg 15-16
• 50 Powell J,Tempest-Roe J. Emotional aspects of GBS.After GBS:2000 pg 16-19.
• 51 Merkies.IS, Schmitz. PIM. Fatigue in immune mediated polyneuropathies.Neurol 1999;53:1684-1654.
• 52 Billard C, Ponsot G, Lyon G, Arthuis M. Acute polyradiculoneuritis in children. Clinical and developmental aspects. Prognostic factors apropos of 100 cases. Archives Francaises de Pediatrie. 1979;36(2):149-61
• 53 Fletcher DD, Lawn ND. Wolter TD, Wijdicks EF. Long term outcome in patients with Guillain-Barre Syndrome requiring mechanical ventilation. Neurology. 54(12): 2311-5,2000 Jun 27.

Click here for DataSheet